chlortetracycline is a lipid of Polyketides (PK) class. Chlortetracycline is associated with abnormalities such as Granulomatous Disease, Chronic, Infection, Ischemia, Cerebral Ischemia and Cerebral Infarction. The involved functions are known as Regulation, Binding (Molecular Function), Agent, Stimulus and Process. Chlortetracycline often locates in Protoplasm, Plasma membrane, Membrane, Cytoplasm and specific granule. The associated genes with chlortetracycline are FPR1 gene, P4HTM gene, Homologous Gene, HIST1H1C gene and Microbiome. The related lipids are Lysophosphatidylcholines, Sterols, dilauroyl lecithin, seminolipid and Total cholesterol. The related experimental models are Mouse Model.
To understand associated biological information of chlortetracycline, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
chlortetracycline is suspected in Ischemia, Cerebral Ischemia, Cerebral Infarction, Granulomatous Disease, Chronic, Infection, Antibiotic resistant infection and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with chlortetracycline
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
Mouse Model are used in the study 'Chlortetracycline and demeclocycline inhibit calpains and protect mouse neurons against glutamate toxicity and cerebral ischemia.' (Jiang SX et al., 2005).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
PAINE TF et al. | Laboratory studies with aureomycin. | 1948 | Ann. N. Y. Acad. Sci. | pmid:18124197 |
BRALEY AE and SANDERS M | Aureomycin in ocular infections; a preliminary report. | 1948 | J Am Med Assoc | pmid:18883235 |
COOKE C | Rocky Mountain spotted fever treated with aureomycin. | 1948 | J Am Med Assoc | pmid:18890443 |
MEADS M et al. | In vitro observations on the antibacterial activity of aureomycin. | 1948 | N C Med J | pmid:18890720 |
FINLAND M et al. | Aureomycin, a new antibiotic; results of laboratory studies and of clinical use in 100 cases of bacterial infections. | 1948 | J Am Med Assoc | pmid:18892416 |
GREENBLATT RB and DIENST RB | Oral aureomycin in the therapy of streptomycin-resistant granuloma inguinale. | 1948 | South. Med. J. | pmid:18892826 |
Paine TF et al. | Bacteriologic Studies on Aureomycin. | 1948 | J. Bacteriol. | pmid:16561597 |
COLLINS HS and PAINE TF | Aureomycin; a new antibiotic; evaluation of its effects in typhoid fever, severe salmonella infections and in a case of colon bacillus bacteremia. | 1948 | Ann. Intern. Med. | pmid:18100407 |
COLLINS HS et al. | Aureomycin in treatment of pneumococcal pneumonia and meningococcemie. | 1948 | Proc. Soc. Exp. Biol. Med. | pmid:18102197 |
ROSS S and SCHOENBACH EB | Aureomycin therapy of Rocky Mountain spotted fever. | 1948 | J Am Med Assoc | pmid:18103383 |